mosunetuzumab
roche
['mosunetuzumab']
. dr. matthew matasar ( ) &amp; colleagues present mosunetuzumab monotherapy demonstrates durable efficacy with a manageable safety profile " at #ash22. 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.